URGN
Urogen Pharma
$34.04
−$0.45 (−1.3%)Oct 26, 2026
Key metrics
The numbers that frame URGN today
- Market cap
- $1.66B
- Gross margin
- 90.8%
- EV / Sales
- 9.4
- ROIC
- -34.7%
- Div yield
- 0%
- 52wk Low
- $16.50
- 52wk High
- $50.81
Growth
Revenue and earnings trend for URGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about URGN
Is Urogen Pharma a good buy?
Yes. Urogen Pharma has excellent momentum, and it outweighs the poor quality here. Growth looks excellent, which supports the long-term business case. We think Urogen Pharma is selling at a high price, which cuts against the buy case.
What is the market capitalization of URGN?
Urogen Pharma's market capitalization is $1.66B.
What is the 52-week high for URGN stock?
The 52-week high for Urogen Pharma is $50.81. The current close of $34.04 is 33% below that high.
What is the 52-week low for URGN stock?
The 52-week low for Urogen Pharma is $16.50. The current close of $34.04 is 106.3% above that low.
Does URGN stock pay dividends?
Urogen Pharma does not currently show a dividend per share in the company data.